论文部分内容阅读
在CAST和ESVEM试验中,Ⅰ类药物的效率欠佳,在ESVEM试验中索他洛尔的作用优于6种药物,有人据此认为宜用Ⅲ类药物治疗室性快速心律失常和心脏骤停。作者持相反意见,并作论证。
In the CAST and ESVEM trials, the inefficacy of class I drugs is better than that of sotalol in ESVEM trials, and some have suggested that class III drugs should be used to treat ventricular tachyarrhythmias and cardiac arrest . The author holds the opposite opinion and argues.